Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (7)

1

Cabazitaxel for metastatic castration-resistant prostate cancer progressing after docetaxel treatment : the TROPIC study in France

enthalten in: Bulletin du cancer | 2012

von Pouessel, D. | Oudard, S. | Gravis, G. | +3

2

Efficacy assessment of Nutrilarm®, a per os omega-3 and omega-6 polyunsaturated essential fatty acid dietary formulation versus placebo in patients with bilateral treated moderate dry eye syndrome

enthalten in: Journal francais d'ophtalmologie | 2011

von Creuzot-Garcher, C. | Baudouin, C. | Labetoulle, M. | +6

3

Locally advanced unresectable pancreatic cancer : Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2011

von Barhoumi, M. | Mornex, F. | Bonnetain, F. | +13

4

Economic assessment of Caelyx versus topotecan in advanced ovarian cancer

enthalten in: Bulletin du cancer | 2003

von Girre, V. | Pujade-Lauraine, E. | Durand-Zaleski, I.

5

Bisprolol in heart failure : efficacy and costs in a French setting according to CIBIS II

enthalten in: Therapie | 2001

von Lévy, P. | Mérot, J. | Lechat, P. | +2

6

Economic study of carvedilol in heart failure. A cost effectiveness study in France

enthalten in: Archives des maladies du coeur et des vaisseaux | 2001

von Lévy, P. | Dubois-Randé, J. | Cohen-Solal, A. | +1

7

Hyperfractionated and accelerated radiotherapy in head and neck cancers : results of the EORTC trials and impact on clinical practice

enthalten in: Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique | 1996

von Horiot, J. | Bontemps, P. | Begg, A. | +13

1
[1]